Cancer and Diagnostics

Oncology Biomarkers

Researchers are encouraged to submit abstracts for the "Oncology Biomarkers" track at the "World Cancer 2024" conference, focusing on the latest advancements in biomarker discovery, validation, and clinical application in oncology. Abstracts should highlight novel biomarkers, diagnostic assays, predictive models, and therapeutic targets with potential implications for cancer diagnosis, prognosis, treatment response, and precision medicine.

Attendees can expect presentations on cutting-edge biomarker technologies, including genomics, proteomics, metabolomics, and imaging-based biomarkers, as well as discussions on biomarker-driven clinical trials, personalized treatment strategies, and regulatory considerations. The track will also feature sessions on biomarker standardization, data integration, and collaborative efforts to accelerate biomarker research and translation into clinical practice.